These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22851059)

  • 1. Perioperative assessment of platelet function by Thromboelastograph Platelet Mapping in cardiovascular patients undergoing non-cardiac surgery.
    Cattano D; Altamirano AV; Kaynak HE; Seitan C; Paniccia R; Chen Z; Huang H; Prisco D; Hagberg CA; Pivalizza EG
    J Thromb Thrombolysis; 2013 Jan; 35(1):23-30. PubMed ID: 22851059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping.
    Collyer TC; Gray DJ; Sandhu R; Berridge J; Lyons G
    Br J Anaesth; 2009 Apr; 102(4):492-8. PubMed ID: 19286767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
    Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
    Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry.
    Agarwal S; Coakley M; Reddy K; Riddell A; Mallett S
    Anesthesiology; 2006 Oct; 105(4):676-83. PubMed ID: 17006064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastograph with Platelet Mapping(TM) predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting.
    Chowdhury M; Shore-Lesserson L; Mais AM; Leyvi G
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):217-23. PubMed ID: 24630471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
    Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
    Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of three platelet function tests in ischemic stroke patients with antiplatelet therapy.
    Shao T; Cheng Y; Jin J; Huang L; Yang D; Luo C; Han Z; Wang Z; Ge W; Xu Y
    J Clin Neurosci; 2020 Aug; 78():91-96. PubMed ID: 32624366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial.
    Rafiq S; Johansson PI; Zacho M; Stissing T; Kofoed K; Lilleør NB; Steinbrüchel DA
    Trials; 2012 Apr; 13():48. PubMed ID: 22540524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery.
    Lev EI; Ramchandani M; Garg R; Wojciechowski Z; Builes A; Vaduganathan M; Tripathy U; Kleiman NS
    J Thromb Thrombolysis; 2007 Aug; 24(1):15-21. PubMed ID: 17277998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin.
    Siller-Matula JM; Delle-Karth G; Christ G; Neunteufl T; Maurer G; Huber K; Tolios A; Drucker C; Jilma B
    Int J Cardiol; 2013 Jul; 167(2):430-5. PubMed ID: 22305813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
    Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
    Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?
    Bagoly Z; Homoródi N; Kovács EG; Sarkady F; Csiba L; Édes I; Muszbek L
    Platelets; 2016; 27(1):59-65. PubMed ID: 26083485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.
    Metzler H; Prüller F; Münch A; Primus G; Kainz J; Hödl R; Rehak P
    Eur J Anaesthesiol; 2010 Feb; 27(2):138-45. PubMed ID: 19593147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of aspirin vs. clopidogrel in dogs with immune mediated haemolytic anaemia evaluated by serial thromboelastography and platelet mapping.
    Griebsch C; Hall E; Barrs VR
    Vet J; 2022 Sep; 287():105882. PubMed ID: 35963596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Mahla E; Metzler H; Bornemann-Cimenti H; Prueller F; Raggam RB; Pregartner G; Berghold A; Baumann A; Goeroeg C; Gurbel PA
    Thromb Haemost; 2018 May; 118(5):864-872. PubMed ID: 29625498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-centre, randomised study on platelet reactivity after abrupt or gradual discontinuation of long-term clopidogrel therapy in patients after percutaneous coronary intervention.
    Nadrowski P; Syzdół M; Wańha W; Nabiałek E; Skrzypek M; Góral J; Siewniak M; Kozakiewicz K; Ochała A; Tendera M; Wojakowski W
    Kardiol Pol; 2016; 74(7):634-43. PubMed ID: 26779855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?
    Swallow RA; Agarwala RA; Dawkins KD; Curzen NP
    Platelets; 2006 Sep; 17(6):385-92. PubMed ID: 16973499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.